Hempstract(OTC) HPST

Hempstract, Inc. is a U.S.-based company specializing in the development and supply of cannabidiol (CBD) and cannabigerol (CBG) products. The company offers a range of products, including CBD isolate powder and various distillate oils, catering to the growing demand in the health and wellness sector.

Products and Services

• CBD isolate powder for various applications
• Distillate oils with diverse formulations
• Custom product development for specific market needs

Growth Outlook

• Expanding market for CBD and CBG products projected to grow significantly
• Increased consumer awareness driving demand for health-focused products
• Strategic partnerships may enhance distribution channels and market reach

Financial Highlights

• Recent quarterly net income of -$102,866, reflecting ongoing operational challenges
• Trailing twelve months (TTM) revenue of $0, indicating a need for revenue generation strategies
• Current ratio of 1.63 suggests adequate short-term liquidity

Hempstract, Inc. operates in the Drug Manufacturers - Specialty & Generic industry, focusing on the burgeoning market for CBD and CBG products. The company has undergone a rebranding from Riverdale Oil and Gas Corporation to Hempstract, Inc. in November 2020, aligning its identity with its core business. The firm is headquartered in Warden, Washington, and employs a small team dedicated to product development and market expansion. Despite facing challenges reflected in recent financial performance, including a net income loss and zero revenue, the company maintains a current ratio above 1, indicating a solid liquidity position. The growth outlook remains positive, driven by increasing consumer interest in health and wellness products, particularly those derived from hemp. As the market continues to evolve, Hempstract, Inc. is positioned to leverage its product offerings and potential partnerships to capture a share of this expanding sector.